<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font6" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="48" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>CytoJournal</i></text>
<text top="41" left="103" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2006, </text>
<text top="41" left="131" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="136" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:18</text>
<text top="41" left="387" width="167" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.cytojournal.com/content/3/1/18</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t6" reading_order_no="112" segment_no="13" tag_type="text">Page 2 of 8</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="113" segment_no="14" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">NMP22, cytokeratin 20 and human complement factors,</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">but the results with cytological preparations have been</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">conflicting <a href="">[2-4]. No</a> single diagnostic technique alone is</text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">sufficient to establish the diagnosis in all cases, and the</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">search for an accurate tumor marker that reliably confirms</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">urothelial malignancy remains a challenge. Promising fac-</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">tors in this context are components of the human telom-</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">erase enzyme complex. The human telomerase reverse</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">transcriptase (hTERT) protein is the catalytic subunit of</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text">the telomerase holoenzyme which maintains chromo-</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">somal telome<a href="">res [5</a>]. Telomeres are the non-coding ter-</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text">mini of eukaryotic chromosomes and function to stabilize</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">and maintain chromosomal structure. However, telom-</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="2" tag_type="text">eric DNA is lost at each cell division as a result of the ina-</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="2" tag_type="text">bility of DNA polymerases to replicate the 5' end of linear</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="2" tag_type="text">DN<a href="">A [6</a>], and erosion of these sequences beyond a critical</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="2" tag_type="text">point is thought to signal cell cycle arrest and entry into</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="2" tag_type="text">cellular senescence <a href="">[7]. T</a>he major mechanism of telomere</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="2" tag_type="text">repair or maintenance is mediated by the enzyme telom-</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="2" tag_type="text">erase [<a href="">5]. A clo</a>se association between the activation of the</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="2" tag_type="text">telomerase enzyme and cellular immortality has been</text>
<text top="333" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="2" tag_type="text">established, and the presence of functional telomerase</text>
<text top="345" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="2" tag_type="text">enables cells to be capable of extended proliferation or to</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="2" tag_type="text">become immortal, and in concordance with this hypoth-</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="2" tag_type="text">esis, telomerase activity has been detected in the great</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="2" tag_type="text">majority of malignant tumor specimens te<a href="">sted [8,9]. The</a></text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="2" tag_type="text">enzyme is undetectable in normal somatic cells; therefore,</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="2" tag_type="text">the detection of telomerase activity in human tissue sam-</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="2" tag_type="text">ples has value for the recognition of malignant cells in</text>
<text top="427" left="55" width="99" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="2" tag_type="text">clinical spec<a href="">imens [10</a>].</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="9" tag_type="text">For detecting telomerase activity in a tissue specimen the</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="9" tag_type="text">TRAP assay is a relatively sensitive and specific method,</text>
<text top="474" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="9" tag_type="text">but it can be used only on fresh tissue extracts and offers</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="9" tag_type="text">no information at the cellular level <a href="">[11]. Expr</a>ession of</text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="9" tag_type="text">hTERT mRNA is very closely associated with telomerase</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="9" tag_type="text">activity in human tumors and can be detected by RT-PCR</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="9" tag_type="text"><a href="">[12]. Ho</a>wever, this approach also does not offer any</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="9" tag_type="text">information at the level of the individual cell and so cor-</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="9" tag_type="text">relative comparison of molecular data with cellular mor-</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="9" tag_type="text">phology is not attainable. Therefore,</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="9" tag_type="text">immunohistochemical (IHC) methods of hTERT protein</text>
<text top="580" left="55" width="143" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="9" tag_type="text">evaluation, which can both detect </text>
<text top="580" left="198" width="17" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="9" tag_type="text"><i>and </i></text>
<text top="580" left="215" width="81" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="9" tag_type="text">localize cellular tel-</text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="9" tag_type="text">omerase expression in human tissue would be optimal for</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="9" tag_type="text">the differential diagnosis of cellular material such as</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="9" tag_type="text">serous effusions. Investigators have recently tested com-</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="9" tag_type="text">mercially available anti-hTERT antibodies in formalin-</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="9" tag_type="text">fixed and paraffin-embedded human tissues by IHC</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="9" tag_type="text"><a href="">[13,31]</a>. One monoclonal antibody (NCL-hTERT;</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="9" tag_type="text">Novacastra) was sufficiently specific for further investiga-</text>
<text top="674" left="55" width="110" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="9" tag_type="text">tion in clinical specimens.</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="12" tag_type="text">In this study, we applied the hTERT antibody to urine sed-</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="12" tag_type="text">iment cytology samples prepared as paraffin sections of</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="12" tag_type="text">cell blocks. We evaluated over one hundred cell blocks for</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">hTERT immunoreactivity, and compared the findings</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">with available conventional cytology and biopsy pathol-</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">ogy information. When present, the expression of hTERT</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">protein was localized to the nucleoli of urothelial cells,</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="3" tag_type="text">and hTERT expression positively correlated with urothe-</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="3" tag_type="text">lial cell neoplasia. Whilst conventional cytology plays a</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="3" tag_type="text">pivotal role in the diagnosis of bladder cancer, for difficult</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="3" tag_type="text">cases, in which ancillary information is necessary, the use</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="3" tag_type="text">of immunohistochemical detection of the telomerase</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="3" tag_type="text">component hTERT may significantly improve diagnostic</text>
<text top="204" left="313" width="38" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="3" tag_type="text">accuracy.</text>
<text top="228" left="313" width="43" height="10" font="font6" id="p1_t74" reading_order_no="71" segment_no="4" tag_type="title"><b>Methods</b></text>
<text top="240" left="313" width="75" height="9" font="font7" id="p1_t75" reading_order_no="72" segment_no="5" tag_type="title"><i><b>Patient specimens</b></i></text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="6" tag_type="text">In total, 101 cell blocks that contained various bladder tis-</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="6" tag_type="text">sue specimens were identified in the archives of the</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="6" tag_type="text">Shands &amp; University of Florida Hospital, Jacksonville, FL.</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="6" tag_type="text">Cell blocks were prepared from urinary sediments col-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="6" tag_type="text">lected from patients under investigation for bladder</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="6" tag_type="text">lesions of various types. The urinary sediments were proc-</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="6" tag_type="text">essed into cell blocks using the plasma/thrombin tech-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="6" tag_type="text"><a href="">nique [14]</a>. Evaluated specimens were selected according</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="6" tag_type="text">to the cytological diagnosis and included 29 malignant</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="6" tag_type="text">cases, 39 non-malignant cases, and 33 cases of cytological</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="6" tag_type="text">atypia. Tissue biopsy confirmation of malignant and</text>
<text top="380" left="313" width="185" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="6" tag_type="text">benign conditions was available in 56 cases.</text>
<text top="404" left="313" width="61" height="9" font="font7" id="p1_t88" reading_order_no="85" segment_no="7" tag_type="title"><i><b>Urine cytology</b></i></text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="8" tag_type="text">Smears of urine specimens from each patient were exam-</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="8" tag_type="text">ined cytologically by standard Papanicolaou staining. All</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="8" tag_type="text">slides were evaluated routinely by an experienced</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="8" tag_type="text">cytopathologist without any prior knowledge of the</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="8" tag_type="text">immunohistochemical findings. Urothelial carcinoma</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="8" tag_type="text">grading and staging were performed according to the</text>
<text top="486" left="313" width="150" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="8" tag_type="text">World Health Organization criteria.</text>
<text top="510" left="313" width="94" height="9" font="font7" id="p1_t96" reading_order_no="93" segment_no="10" tag_type="title"><i><b>Immunohistochemistry</b></i></text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="11" tag_type="text">The specificity of the antibody has been reported in previ-</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="11" tag_type="text">ous reports <a href="">[13</a>,<a href="">31</a>]. Antibody-mediated detection of</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="11" tag_type="text">hTERT was performed using the standard streptavidin-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="11" tag_type="text">biotin peroxidase complex method. All steps were per-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="11" tag_type="text">formed on a Ventana Benchmark XT-BTS automatic</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="11" tag_type="text">immunostainer (Tucson, Arizona). Tissue sections from</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="11" tag_type="text">representative blocks were deparaffinized in xylene and</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="11" tag_type="text">alcohols, and were then placed in 3% hydrogen peroxide/</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="11" tag_type="text">methanol for 5 minutes to block nonspecific background</text>
<text top="627" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="11" tag_type="text">staining due to endogenous peroxidase activity. Antigen</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="11" tag_type="text">epitopes were retrieved (Ventana Benchmark CC1</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="11" tag_type="text">extended program) by heating to 100°C and reducing</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t109" reading_order_no="106" segment_no="11" tag_type="text">heat slowly over a 90 min period at pH 8.0. The primary</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t110" reading_order_no="107" segment_no="11" tag_type="text">antibody (NCL-hTERT IgG 2a, Batch # 147508, from</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t111" reading_order_no="108" segment_no="11" tag_type="text">Novocastra, Newcastle-upon-Tyne, UK) was diluted 1:25</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t112" reading_order_no="109" segment_no="11" tag_type="text">and applied to the slides for 32 min at 37°C. Secondary</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t113" reading_order_no="110" segment_no="11" tag_type="text">antibody incubation, washes and chromogen (3,3'-diami-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t114" reading_order_no="111" segment_no="11" tag_type="text">nobenzidine) development were performed at room tem-</text>
</page>
</pdf2xml>
